Evidence map›Paper›PMID 41429721›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

Relative biological effectiveness and neural stem cell fate in carbon ion-irradiated human brain organoids.

Tamara Bender, Marco Durante, Insa S Schroeder

Abstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tamara BenderGSI Helmholtzzentrum für Schwerionenforschung, Biophysics Department, Darmstadt, Germany.
Marco DuranteGSI Helmholtzzentrum für Schwerionenforschung, Biophysics Department, Darmstadt, Germany; Institute for Condensed Matter Physics, Technische Universität Darmstadt, Darmstadt, Germany; Department of Physics "Ettore Pancini", University Federico II, Naples, Italy.
Insa S SchroederGSI Helmholtzzentrum für Schwerionenforschung, Biophysics Department, Darmstadt, Germany. Electronic address: i.schroeder@gsi.de.

Funding

Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid modelR01CA256848 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GROSSHANS, DAVID R · 2021 to 2025
$2.3M
NCI NIH HHS R01 CA256848
6 · The paper itself

Abstract

background and purposeHeavy ion therapy offers a promising approach for treating brain tumors due to the high precision of ion beams and biological effectiveness. However, the mechanisms underlying contrast-enhanced brain lesions, which occur more frequently after ions than conventional X-rays, remain to be elucidated. MATERIALS AND

methodsCerebral organoids were generated from human embryonic stem cells and exposed to high-energy carbon-ions at early (day 20) and late (day 80) developmental stages. Analyses of gene expression were performed using RT-PCR analysis, and protein expression was assessed using immunofluorescence staining.

resultsWe demonstrate that exposure to high-energy carbon (C)-ions induces the formation of ectopic choroid plexus (CP)-like structures in human cerebral organoids. RT-PCR analyses revealed that C-ion exposure alters the differentiation trajectories of neuroepithelial stem cells, driven by dysregulation of key developmental signaling pathways including NOTCH, WNT, and BMP. Moreover, we observed increased expression of CP-associated markers AQP1 and CLDN3. The relative biological effectiveness (RBE) of C-ions for the formation of fluid-filled cavities associated with CP-like tissue was calculated as 2.0 after both 60 and 100 days of differentiation.

conclusionOur findings indicate that aberrant CP development is a central mechanism underlying post-radiation contrast-enhanced brain lesions, and that an RBE of 2 should be considered when determining dose thresholds for normal tissue tolerance in carbon ion therapy for brain tumors.

Indexed as

BrainHeavy Ion RadiotherapyNeural Stem CellsOrganoidsBrain NeoplasmsCell DifferentiationHumansRelative Biological EffectivenessBrain lesionsCarbon ionsCerebral organoidsChoroid plexusParticle therapy

Identifiers

PMID41429721
PMCPMC13421752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.